ZOETIS financials
$69.83−0.67%
Close Sep 30, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.47B | $2.26B | $2.39B | $2.40B | $2.47B | $2.20B | $2.32B | $2.39B | $2.36B | $2.19B | $2.21B | $2.15B |
| Gross profit | $1.79B | $1.62B | $1.68B | $1.72B | $1.81B | $1.58B | $1.61B | $1.69B | $1.69B | $1.55B | $1.49B | $1.51B |
| Gross margin | 72.7% | 71.7% | 70.2% | 71.5% | 73.2% | 71.9% | 69.5% | 70.6% | 71.7% | 70.6% | 67.1% | 70.3% |
| Operating income | $922.0M | $800.0M | $809.0M | $932.0M | $967.0M | $812.0M | $763.0M | $915.0M | $864.0M | $797.0M | $701.0M | $782.0M |
| Net income | $691.0M | $601.0M | $603.0M | $721.0M | $726.0M | $602.0M | $581.0M | $682.0M | $624.0M | $599.0M | $525.0M | $596.0M |
| Net margin | 28.0% | 26.6% | 25.3% | 30.0% | 29.3% | 27.4% | 25.1% | 28.6% | 26.4% | 27.4% | 23.7% | 27.7% |
| Diluted EPS | $1.65 | $1.42 | $1.37 | $1.63 | $1.63 | $1.34 | $1.29 | $1.50 | $1.37 | $1.31 | $1.14 | $1.29 |
| EBITDA | $1.12B | $941.0M | $947.0M | $1.06B | $1.12B | $931.0M | $888.0M | $1.04B | $1.03B | $927.0M | $858.0M | $922.0M |
| Operating cash flow | $655.0M | $401.0M | $893.0M | $938.0M | $605.0M | $515.0M | $905.0M | $951.0M | $502.0M | $595.0M | $897.0M | $724.0M |
| Free cash flow | $538.0M | $291.0M | $732.0M | $805.0M | $459.0M | $337.0M | $689.0M | $784.0M | $370.0M | $455.0M | $699.0M | $579.0M |
| Diluted shares | 417.7M | 422.4M | 438.6M | 443.2M | 445.5M | 448.0M | 451.1M | 453.5M | 456.0M | 458.8M | 460.2M | 461.4M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.48B | $1.94B | $2.45B | $2.08B | $1.44B | $1.72B |
| Short-term investments | $200.0M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $9.05B | $9.04B | $9.04B | $7.07B | $6.58B | $6.58B |
| Total assets | $15.08B | $15.15B | $15.49B | $15.16B | $14.48B | $14.10B |
| Total liabilities | $11.93B | $11.92B | $12.07B | $9.76B | $9.50B | $9.44B |
| Shareholders' equity | $3.15B | $3.23B | $3.42B | $5.40B | $4.98B | $4.66B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology